Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schrör

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Zeitschrift Fur Kardiologie|January 1, 1992
[Thromboxane A2 and prevention of cardiovascular diseases]K Schrör
Der Internist|January 11, 2015
[Aspirin and venous thromboses]K Schrör
Wiener Klinische Wochenschrift|March 27, 1999
[Anti-integrins--new platelet function inhibitors for therapy and prevention of acute coronary syndrome]K Schrör
VASA. Supplementum|January 1, 1991
[Pharmacologic concepts for clinical use of prostaglandin E1]K Schrör
Wiener Klinische Wochenschrift|January 18, 1985
[Genetic defects of prostaglandin and thromboxane synthesis]K Schrör
Zeitschrift Fur Kardiologie|January 1, 1985
[Prostaglandins and endothelial cells]K Schrör
Journal of Cardiovascular Pharmacology|January 1, 1990
Converting enzyme inhibitors and the interaction between kinins and eicosanoidsK Schrör
Arzneimittel-Forschung|February 1, 1993
Prostaglandin-mediated actions of the renin-angiotensin systemK Schrör
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 1979
The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculatureK Schrör
Seminars in Thrombosis and Hemostasis|January 1, 1997
Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxisK Schrör
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Zeitschrift Fur Kardiologie|January 1, 1992
[Thromboxane A2 and prevention of cardiovascular diseases]K Schrör
Der Internist|January 11, 2015
[Aspirin and venous thromboses]K Schrör
Wiener Klinische Wochenschrift|March 27, 1999
[Anti-integrins--new platelet function inhibitors for therapy and prevention of acute coronary syndrome]K Schrör
VASA. Supplementum|January 1, 1991
[Pharmacologic concepts for clinical use of prostaglandin E1]K Schrör
Wiener Klinische Wochenschrift|January 18, 1985
[Genetic defects of prostaglandin and thromboxane synthesis]K Schrör
Zeitschrift Fur Kardiologie|January 1, 1985
[Prostaglandins and endothelial cells]K Schrör
Journal of Cardiovascular Pharmacology|January 1, 1990
Converting enzyme inhibitors and the interaction between kinins and eicosanoidsK Schrör
Arzneimittel-Forschung|February 1, 1993
Prostaglandin-mediated actions of the renin-angiotensin systemK Schrör
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 1979
The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculatureK Schrör
Seminars in Thrombosis and Hemostasis|January 1, 1997
Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxisK Schrör
Pageof 23